New drug corresponding disease

Showing 157–168 of 201 results

  • Non-small cell lung cancer (NSCLC)

    Coloritinib

    【Product name】Zykadia

    [English common name]Ceritinib

    [Chinese common name]Coloritinib

    [English name]

    [Chinese other name]

    [Indications] Zykadia is a kinase inhibitor for anaplastic lymphoma kinase (ALK)-positive metastasis that has progressed or is intolerant after treatment with crizotinib.Non-small cell lung cancer (NSCLC)Treatment of the patient.

    【Usage and Dosage】 Oral 750mg once a day. Zykadia is given on an empty stomach (ie, not given within 2 hours of the meal).

    [Storage] Store at 25 ° C (77 ° F); allowable deviation between 15 ° C and 30 ° C (59 ° F to 86 ° F).

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Type 2 diabetes

    Exenatide

    【Product name】BYDUREON, Byetta

    [English common name]Exenatide

    [Chinese common name]Exenatide

    [English name]

    [Chinese other name]

    [Indications] BYDUREON is a glucagon-like peptide-1 (GLP-1) receptor agonist that is used as an adjunct to diet and exercise to improve glycemic control.Type 2 diabetesAdulthood is in a variety of clinical situations. BYDUREON is a sustained release formulation of exenatide. Do not give it at the same time as BYETTA.

    [Usage and Dosage] Give 2 mg once every 7 days (weekly) by subcutaneous injection, with or without meals during any daytime. It is administered immediately after suspension of the powder.

    [Storage] will be new unusedByettaStored at 36°F to 46°F (2°C to 8°C).

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • 血小板减少症

    艾曲波帕

    【英文名】Eltrombopag

    【英文商品名】Revolade

    [Chinese common name]艾曲波帕

    【适应症】适用于既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人（≥18周岁）慢性免疫性（特发性）血小板减少症（ITP）患者，使血小板计数升高并减少或防止出血。

    【用法用量】艾曲波帕的建议起始剂量为 25mg每日一次。

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Adult hereditary angioedema (HAE)

    Etibatant

    【Product name】Firazyr

    [English common name]Icitabant

    [Chinese common name]Etibatant

    [English name]HOE 140

    [Chinese other name]

    [indications]Hereditary angioedema(HAE).

    【Dosage】
    (1) Subcutaneous injection of 30 mg abdominal area.
    (2) If the reaction is inappropriate or the symptoms recur, 30 mg is injected at least 6 hours apart.
    (3) Do not give more than 3 injections within 24 hours.
    (4) The patient recognizes that a HAE episode can be administered by itself.

    [Storage] Do not store at 25 ° C or above. Do not freeze.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Type II mucopolysaccharidosis (MPSII) , Hunter syndrome

    Idusulfate

    【Product name】Elaprase

    [English common name]Idursulfase

    [Chinese common name]Idusulfate

    [English name]

    [Chinese other name]

    [Indications] Elaprase is suitable for long-term treatment of patients with Hunter syndrome (Mucopolysaccharide storage disease II, MPS II). Heterozygous females were not studied in clinical trials.

    [Usage and Dosage] Use this medicine exactly as the doctor told you. If you are not sure, please consult your doctor.
    This medicine will be given to you under the supervision of a doctor or nurse who specializes in treating Hunter's syndrome or other hereditary metabolic disorders.
    The recommended dose is 0.5 mg (half mg) per kg of infusion. Before use, Elaprase must be diluted in sodium chloride 9 mg / ml (0.9%) for infusion. After dilution, the drug is administered by intravenous (drip). The infusion usually lasts for 1 to 3 hours and is administered weekly. The recommended dose for children and adolescents and adolescents is the same as for adults.
    If you use more Elaprase than you should
    There is no experience with this drug overdose.
    If you forget to use Elaprase
    If you missed the Elaprase infusion, please contact your doctor.
    If you have any questions about using this medicine, please consult your doctor or nurse.

    [Storage] Store in the refrigerator (2 ° C – 8 ° C). Do not freeze.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Chronic obstructive pulmonary disease (COPD)

    Indole bromide/triphenylacetate

    【Product name】Anoro Ellipta

    [English common name]Umeclidinium and vilanterol

    [Chinese common name]Indole bromide/triphenylacetate

    [English name]Umeclidinium bromide

    [Chinese other name]Indole bromide

    [Indications] ANORO ELLIPTA is not suitable for relieving acute bronchospasm or treatmentasthma.

    [Usage and dosage] should be given ANORO ELLIPTA (umeclidinium / vilanterol 62.5 mcg / 25 mcg)
    Inhaled only once a day by oral inhalation. ANORO ELLIPTA should be taken at the same time every day. Do not use ANORO
    ELLIPTA exceeds every 24 hours. In elderly patients, patients with renal insufficiency or patients with moderate hepatic impairment do not need to adjust the dose.

    [Storage] Store at 68°F to 77°F (20°C to 25°C) at room temperature; tour is allowed from 59°F to 86°F (15°C to 30°C) [see USP Control room temperature]. Store in a dry place away from direct heat or sunlight. Keep this product out of the reach of children.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Multiple sclerosis , Multiple sclerosis

    Fingolimod

    【Product name】Gilenya

    [English common name]Fingolimod

    [Chinese common name]Fingolid

    [English name]

    [Chinese other name]

    [indications]
    Fingolimod capsule: GILENYA is a sphingosine 1-phosphate receptor modulator for relapsingMultiple sclerosisThe patient's treatment reduces the frequency of clinical exacerbations and delays the accumulation of physical disability.

    【Dosage】
    Fingolimod capsules: Recommended dose: 0.5 mg orally once a day, with or without food.

    [Storage]
    Fingolimod capsules: Do not store above 25 °C.
    Stored in original packaging to protect against moisture

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Type 2 diabetes

    Alogliptin benzoate

    【Product name】Nesina

    [English common name]Alogliptin

    [Chinese common name]Alogliptin benzoate tablets

    [English name]Alogliptine, Alogliptina

    [Chinese other name]Aglirel, Alorie Stop

    [indications]This product is suitable for treatmentType 2 diabetes.
    (1) monotherapy
    This product is used as an adjunct to diet control and exercise to improve glycemic control in patients with type 2 diabetes.
    (2) in combination with metformin hydrochloride
    When metformin hydrochloride alone is not effective in controlling blood glucose, this product can be combined with metformin hydrochloride to improve glycemic control in patients with type 2 diabetes on a diet and exercise basis.
    (3) Important use restrictions
    Because the effectiveness of type 1 diabetes and diabetic ketoacidosis has not been determined, this product is not intended for patients with type 1 diabetes or diabetic ketoacidosis.

    【Dosage】Recommended dose
    1. Nishina's recommended dose is 25mg once daily.
    2. Nishin can be taken at the same time or separately from the food.
    3. Patients with impaired renal function
    (1) Patients with mild renal impairment (creatinine clearance [CrCl] ≥ 60 mL / min) Nisin was not required to adjust the dose at that time.
    (2) Patients with moderate renal impairment (creatinine clearance [CrCl] ≥ 30 to < 60 mL / min) The dose of Nishina was 12.5 mg once daily.
    (3) Patients with severe renal impairment (creatinine clearance [CrCl] ≥ 15 to < 30 mL / min) or end-stage renal failure (ESRD) (CrCl < 15 mL / min or need hemodialysis) patients with Nishina dose For 6.25 mg once daily. Nixin can be used without considering dialysis time. Nishina medication studies have not been performed in patients undergoing peritoneal dialysis (see [Pharmacokinetics]).
    Because of the need to adjust the Nishina dose according to renal function, it is recommended to evaluate renal function before starting treatment and review it regularly.

    [Storage] Store at 25 ° C (77 ° F); Allow 15 ° to 30 ° C (59 ° to 86 ° F) offset [see USP controlled room temperature].

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Chronic lymphocyte leukemia

    Bendamustine

    【Product name】Treanda, Levact, Levact

    [English common name]Bendamustine

    [Chinese common name]Bendamustine

    [English name]Treanda Powder Vial

    [Chinese other name]

    [indications]
    1.Chronic lymphocyte leukemia(CLL). The efficacy of first-line therapy different from chlorambucil has not been established.
    2. Inert B cells in the course of treatment with rituximab (rituximab) or rituximab regimen, or within 6 months of treatment, the condition is still progressingHodgkin's lymphoma(NHL) patients.

    【Dosage】
    Formulation process: The drug should be dissolved in 20 ml of sterile water for injection every 100 mg, and shaken thoroughly until it is completely dissolved into a clear, colorless or light yellow solution. The dissolution time is generally less than 5 minutes, and the concentration after dissolution is 5 mg/ml. Within 30 minutes after dissolution, an appropriate amount of aqueous solution of bendamustine was taken as needed, and transferred to 500 ml of sodium chloride injection (0.9%) or glucose sodium chloride injection (2.5%/0.45%) to ensure benzene. The final concentration of damolastine in the injection is between 0.2 and 0.6 mg/ml. The prepared injection can be stored at 2-8 ° C for 24 hours or at room temperature under natural light for 3 hours.
    Bendamustine treatment of CLL takes 28 days as a treatment cycle and typically requires 6 treatment cycles. On the first and second days of each treatment cycle, the recommended dose is 100 mg/m2. The drug is administered by intravenous drip, and the time of each administration should not be less than 30 minutes.
    Bendamustine treatment of NHL takes 21 days as a treatment cycle and typically requires 8 treatment cycles. On the first and second days of each treatment cycle, the recommended dose is 120 mg/m2. The time of each administration should not be less than 60 minutes.

    [Storage] The storage temperature of the drug should not exceed 30 ° C, stored in the dark, and temporarily prepared before use.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Chronic obstructive pulmonary disease (COPD)

    茚达特罗

    【Product name】Onbrez, UTIBRON, Ultibro

    [English common name]Indacaterol

    [Chinese common name]茚达特罗

    [English name]Breezhaler

    [Chinese other name]

    [indications]Long-term maintenance therapy for COPD airflow obstruction, including chronic bronchitis and/or emphysema.Use restrictions: can not relieve acute bronchospasm or treatmentasthma.

    【Dosage】Only use the Neohaler device for oral inhalation; Don't swallow your hat.Manage the same time of the day (morning + afternoon).One capsule (27.5mcg / 15.6mcg) was inhaled twice a day.

    [Storage] Store in a dry place at 25 ° C (77 ° F); allow a shift of 15-30 ° C (59-86 ° F) [see USP controlled room temperature].
    75 mcg: Protects capsules from light and moisture.
    ARCAPTA capsules can only be used with NEOHALER inhalers. The NEOHALER inhaler should not be used with any other capsule.
    The capsule should always be stored in the blister and removed from the blister immediately before use.
    Always use the new NEOHALER inhaler provided with each new prescription.
    Keep out of reach of children.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Lung cancer

    Cetuximab

    【Product name】ERBITUX

    [English common name]Cetuximab

    [Chinese common name]Cetuximab

    [English name]

    [Chinese other name]

    [indications]
    1. The efficacy and safety of this drug as adjuvant chemotherapy has not been established.
    2. In consideration of the RAS gene (KRAS and NRAS) in the use of this agent for EGFR-positive unresectable late or relapseColorectal cancerThe presence or absence of a genetic mutation is made to select adaptive patients.
    3. The familiar part of the "clinical results", the efficacy and safety of the drug, as well as the full understanding of the patient's adaptive choice.

    [Usage and Dosage] Adults, once a week, for the first time over 400 mg / square meter (body surface area) for 2 hours, the second and subsequent intravenous injection of 250 mg / square meter (body surface area) within 1 hour. It should be noted that the patient is administered according to this state.

    [Storage]It can be stored for more than 12 hours at 2～8°C, and can be stored for more than 8 hours at 20～25°C.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Colon cancer (mCRC)

    Bevacizumab

    【Product name】Avastin, Cc-Pharma

    [English common name]Bevacizumab

    [Chinese common name]Bevacizumab

    [English name]

    [Chinese other name]

    [indications]
    TransferabilityColorectal cancer(mCRC): Combined with fluorouracil-based chemotherapy as first- or second-line treatment for metastatic colorectal cancer; combined with fluorouracil + irinotecan/oxaliplatin as second-line treatment for metastatic colorectal cancer after first-line therapy.
    2. Non-scalyNon-small cell lung cancer (NSCLC): Combination of carboplatin and paclitaxel for first-line treatment of unresectable, locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer.
    3. Glioblastoma: Bevacizumab alone is effective in the treatment of glioblastoma in adults. The effectiveness of bevacizumab in glioblastoma is based on objective response rates.
    4. TransferabilityRenal cell carcinoma (MRCC): Combined with interferon alpha in the treatment of metastatic renal cell carcinoma.
    5. Cervical cancer: combined with paclitaxel + cisplatin or paclitaxel + topotecan.

    【Dosage】
    1. Metastatic colorectal cancer (mCRC), the recommended dose of bevacizumab: 5 mg / kg or 10 mg / kg, intravenous drip, once every 2 weeks.
    2. Non-squamous non-small cell lung cancer (NSCLC), the recommended dose of bevacizumab is: 15 mg / kg, once every 3 weeks, in combination with carboplatin + paclitaxel.
    3. Glioblastoma, the recommended dose of bevacizumab is: 10 mg / kg, once every 2 weeks.
    4. Metastatic renal cell carcinoma (MRCC), the recommended dose of bevacizumab is: 10 mg / kg, once every 2 weeks, combined with interferon alpha.
    5. Cervical cancer, the recommended dose of bevacizumab is: 15 mg / kg, once every 2 weeks, combined with paclitaxel + cisplatin or paclitaxel + topotecan.

    [Storage] Protected from light and stored and transported in the original packaging at 2°C-8°C. Do not store in cold storage. Don't shake.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.